Drug Trial News

RSS

Older workers generally report low levels of work-related stress

The study, presented in San Francisco at the annual meeting of the Gerontological Society of America, is based on 2006 data from 1,544 participants in the U-M Health and Retirement Study, conducted by the U-M Institute for Social Research (ISR) and funded by the National Institute on Aging.

20 Nov 2007

Physical therapy in intensive care reduce hospital stays

The American Physical Therapy Association (APTA) cites the results of the first study to show the effectiveness of early physical therapy for patients in a medical intensive care unit (ICU).

19 Nov 2007

New organ allocation criteria associated with decreased deaths on liver transplant waiting list

Changing the method by which donated livers are allocated to potential transplant patients appears to have decreased the number of deaths among individuals on the waiting list as well as shortened the time to transplantation, according to a report in the November issue of Archives of Surgery, one of the JAMA/Archives journals.

19 Nov 2007

New HPV vaccine 'nine-valent' under study

A new vaccine against nine of the most harmful strains of human papillomavirus is under study at the Medical College of Georgia.

19 Nov 2007

Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients

A pilot study from researchers at Kyushu University in Fukuoka, Japan, found that narrow band imaging (NBI) colonoscopy used in cancer surveillance for ulcerative colitis patients can identify flat dysplastic lesions.

19 Nov 2007

Managing the chronic care of patients is not being captured in today's reimbursement system

Full-time physicians spend an average of one full day a week providing services for patients that are not reimbursed by Medicare, according to a new study conducted by Jeffrey Farber, MD, Assistant Professor of Geriatrics at The Mount Sinai Medical Center, and published the journal Annals of Internal Medicine.

19 Nov 2007

People with no risk factors for heart disease can still experience heart attacks

An Indiana University study found that after a countywide smoking ban was implemented, hospital admissions for such heart attacks dropped 70 percent for non-smokers -- but not for smokers.

19 Nov 2007

Gene-transfer technique trial for childhood blindness under way

Three decades have passed since gene therapy pioneer William W. Hauswirth, Ph.D., and his colleagues at the University of Florida began work on a virus that could safely deliver corrective genes into living animals.

19 Nov 2007

Increase in eating disorder symptoms among ethnic groups

Eating disorders in the U.S. among ethnic groups were thought to be rare, but recent studies have shown that many cultures are now exposed to the thin beauty ideal.

19 Nov 2007

Drug-eluting stents versus bare-metal stents

Drug-eluting stents are just as safe and effective as traditional bare-metal stents when used in routine clinical practice, according to a new study by researchers at Rhode Island Hospital.

19 Nov 2007

Combining medications often best strategy to battle rheumatoid arthritis

For patients with rheumatoid arthritis, combining one well-known, lower-cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center, which is sponsored by the Agency for Healthcare Research and Quality.

19 Nov 2007

Gene chips provide new technique to evaluate organ rejection in kidney transplants

A new article appearing in American Journal of Transplantation describes a revolutionary technique for more clearly identifying the possibility of organ rejection in kidney transplants.

19 Nov 2007

Better detection accounts for increase in cases of thyroid cancer

Although still rare, the incidence of thyroid cancer is increasing. In this longitudinal study over 12 years from a large cancer registry, Kent and colleagues used the Ontario Cancer Registry to identify 7422 cases of differentiated thyroid cancer from 1990 to 2001.

19 Nov 2007

Subcutaneous administration of an antiemetic for treating vomiting caused by chemotherapy

The subcutaneous administration of granisetron, an antiemetic pharmaceutical drug (suitable for control of vomiting), achieves similar blood concentrations to those administered intravenously.

19 Nov 2007

Some drug studies more likely to have favorable conclusions

Previous work has shown that, when a drug study was funded by the company that made that drug, the results might be biased in favour of that drug because the methods or analyses were manipulated.

19 Nov 2007

Patients taking anti-obesity drugs will only see "modest" weight loss

The study, which looked at the long-term effectiveness of anti-obesity medications, found that three drugs recommended for long-term use - orlistat, sibutramine and rimonabant, reduced weight by less than 5kg (11 pounds). This equated to a loss of less than 5% of total body weight.

19 Nov 2007

High cost of pain in Australia

For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion -- nearly $11,000 for each of the estimated 3.2 million people grappling with pain.

19 Nov 2007

HIV-1 vaccines may not be as reliable against superinfection as once thought

Natural HIV-1 infection does not always elicit a protective immune response, according to a new study published November 16 in PLoS Pathogens.

19 Nov 2007

Buffalo State College receives $3 million grant to study drinking and driving behavior

The Center for Health and Social Research (CHSR) at Buffalo State College has received a $3 million grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to study the initiation and continuation of drinking and driving behavior.

19 Nov 2007

Avastin (bevacizumab) shows promise in phase II study of glioblastoma multiforme

Genentech, Inc. has announced that both study arms of a randomized, multi-center Phase II clinical study of Avastin (bevacizumab) administered alone or in combination with irinotecan chemotherapy demonstrated encouraging six-month progression-free survival (PFS) and objective response rate in patients with relapsed glioblastoma multiforme (GBM), the most common and aggressive type of brain cancer.

19 Nov 2007

Drug Trial News

Older workers generally report low levels of work-related stress

Physical therapy in intensive care reduce hospital stays

New organ allocation criteria associated with decreased deaths on liver transplant waiting list

New HPV vaccine 'nine-valent' under study

Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients

Managing the chronic care of patients is not being captured in today's reimbursement system

People with no risk factors for heart disease can still experience heart attacks

Gene-transfer technique trial for childhood blindness under way

Increase in eating disorder symptoms among ethnic groups

Drug-eluting stents versus bare-metal stents

Combining medications often best strategy to battle rheumatoid arthritis

Gene chips provide new technique to evaluate organ rejection in kidney transplants

Better detection accounts for increase in cases of thyroid cancer

Subcutaneous administration of an antiemetic for treating vomiting caused by chemotherapy

Some drug studies more likely to have favorable conclusions

Patients taking anti-obesity drugs will only see "modest" weight loss

High cost of pain in Australia

HIV-1 vaccines may not be as reliable against superinfection as once thought

Buffalo State College receives $3 million grant to study drinking and driving behavior

Avastin (bevacizumab) shows promise in phase II study of glioblastoma multiforme

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News